Delivery Order SPE2DB22D2108-SPE2DB25FU4KS

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $19,899.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a completion date of May 4, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a specific set-aside designation, indicating open...
This federal contract award, valued at $5,493.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ONFI 10 MG TABLET 100S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,137.10 delivery order is for ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has an ultimate completion date of July 20, 2023 and a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,648.41 firm fixed-price delivery order is for the supply of 4567793636 ! ONFI 10 MG TABLET 100S, with a performance period through April 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,484.83 firm-fixed-price delivery order is for the supply of 4565633265 ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a completion date of August 30, 2024. This award is not set aside for any specific business type. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,895.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract is a firm fixed-price agreement with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,434 firm fixed-price delivery order is for the supply of 4566212032 ONFI 10 MG TABLET 100S, with a final completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $5,558.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,092,588 units of the pharmaceutical product ONFI 10 MG TABLET 100S. The contract has a firm fixed price pricing type and an ultimate completion date of May 1, 2025. This contract award is not associated with a set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,378.42 firm fixed-price delivery order is for the supply of 4,568,114,676 units of the medication ONFI 10 MG TABLET 100S. The contract has an ultimate completion date of May 5, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,764.59 firm fixed-price delivery order is for the supply of 4568187433 - ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a performance period through May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB25FU4KS
    Delivery Order

This federal contract award, valued at $6,059.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568235910 - ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through May 14, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract award is not designated as a set-aside, indicating open competition. No subcontractors are mentioned in the information provided.

Generated 8/12/25, 11:55 AM